- FILTERS Advanced
- Product Type
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- CE / IVD
- Clone ID
- Biosite Product Line
- Supplier
- EXCLUDE FILTERS
- Application
- Species / Reactivity
- Conjugation
- Clone ID
- Biosite Product Line
- Supplier
| Name | Art no | Species Reactivity | Application | Conjugation | Clone | Size | Price |
|---|---|---|---|---|---|---|---|
|
AFT-V4BGOD-1
|
virus
|
ELISA, WB
|
Unconjugated
|
7H4
|
1mg
|
||
|
GTX33911
|
human
|
Inhibition, Neutralization
|
Unconjugated
|
D1(A12)
|
100µg
|
||
|
155-10-137
|
human
|
|
Unconjugated
|
Abagovomab
|
0.1 mg
|
||
|
155-10-167
|
human
|
|
Unconjugated
|
Abciximab
|
0.1 mg
|
||
|
155-10-905
|
human
|
|
Unconjugated
|
Abelacimab
|
0.1 mg
|
||
|
155-10-654
|
human
|
|
Unconjugated
|
Abituzumab
|
0.1 mg
|
||
|
155-10-886
|
human
|
|
Unconjugated
|
Abrezekimab
|
0.1 mg
|
||
|
155-10-660
|
human
|
|
Unconjugated
|
Abrilumab
|
0.1 mg
|
||
|
155-10-483
|
human
|
|
Unconjugated
|
Actoxumab
|
0.1 mg
|
||
|
155-10-186
|
human
|
|
Unconjugated
|
Adalimumab
|
0.1 mg
|
||
|
155-10-185
|
human
|
|
Unconjugated
|
Adecatumumab
|
0.1 mg
|
||
|
155-10-629
|
human
|
|
Unconjugated
|
Aducanumab
|
0.1 mg
|
||
|
155-10-744
|
human
|
|
Unconjugated
|
Afasevikumab
|
0.1 mg
|
||
|
155-10-255
|
human
|
|
Unconjugated
|
Alacizumab
|
0.1 mg
|
||
|
155-10-049
|
human
|
|
Unconjugated
|
Alemtuzumab
|
0.1 mg
|
||
|
155-10-485
|
human
|
|
Unconjugated
|
Alirocumab
|
0.1 mg
|
||
|
155-10-327
|
human
|
|
Unconjugated
|
Altumomab
|
0.1 mg
|
||
|
155-10-086
|
human
|
|
Unconjugated
|
Amatuximab
|
0.1 mg
|
||
|
155-10-966
|
human
|
|
Unconjugated
|
Amivantamab
|
0.1 mg
|
||
|
155-10-298
|
human
|
|
Unconjugated
|
Anatumomab
|
0.1 mg
|
||
|
155-10-684
|
human
|
|
Unconjugated
|
Andecaliximab
|
0.1 mg
|
||
|
155-10-614
|
human
|
|
Unconjugated
|
Anetumab
|
0.1 mg
|
||
|
GTX33914-00
|
human
|
ELISA, Inhibition, Neutralization
|
Unconjugated
|
Angy-1-4
|
100µg
|
||
|
GTX33914
|
human
|
ELISA, Inhibition, Neutralization
|
Unconjugated
|
Angy-1-4
|
100µg
|
||
|
155-10-624
|
human
|
|
Unconjugated
|
Anifrolumab
|
0.1 mg
|
||
|
155-10-253
|
human
|
|
Unconjugated
|
Anrukinzumab
|
0.1 mg
|
||
|
12-9388-50
|
human
|
ELISA, FC
|
|
|
50 µg
|
||
|
12-9388-100
|
human
|
ELISA, FC
|
|
|
100 µg
|
||
|
12-9387-50
|
|
ELISA, FC
|
|
|
50 µg
|
||
|
12-9387-100
|
|
ELISA, FC
|
|
|
100 µg
|
||
|
12-9127-50
|
human
|
FC
|
Unconjugated
|
|
50 µg
|
||
|
12-9127-100
|
human
|
FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9399-50
|
human
|
ELISA, FC
|
|
|
50 µg
|
||
|
12-9399-100
|
human
|
ELISA, FC
|
|
|
100 µg
|
||
|
12-9194-50
|
human
|
ELISA, FC
|
Unconjugated
|
|
50 mg
|
||
|
12-9194-100
|
human
|
ELISA, FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9155-50
|
human
|
FC
|
Unconjugated
|
|
50 mg
|
||
|
12-9155-100
|
human
|
FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9172-50
|
human
|
FC
|
Unconjugated
|
|
50 mg
|
||
|
12-9172-100
|
human
|
FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9137-50
|
human
|
ELISA, FC
|
Unconjugated
|
|
50 µg
|
||
|
12-9137-100
|
human
|
ELISA, FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9196-100
|
human
|
ELISA, FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9196-50
|
human
|
ELISA, FC
|
Unconjugated
|
|
50 mg
|
||
|
BPS-101968-1
|
human
|
|
|
|
50 µg
|
||
|
BPS-101968-2
|
human
|
|
|
|
100 µg
|
||
|
12-9167-100
|
human
|
FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9167-50
|
human
|
FC
|
Unconjugated
|
|
50 mg
|
||
|
12-9143-100
|
human
|
FC
|
Unconjugated
|
|
100 µg
|
||
|
12-9143-50
|
human
|
FC
|
Unconjugated
|
|
50 mg
|